Health Products

Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II

Summary

Product

Hydromorph Contin - Controlled Release Capsule 24 mg

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
135272, 135529, 136263, 137226, 137482, 137934, 138568, 138820, 139454, 139842Hydromorph Contin - Controlled Release Capsule 24 mg
Recalling Firm
Purdue Pharma
575 Granite Court
Pickering
L1W 3W8
Ontario
CANADA
Marketing Authorization Holder
Purdue Pharma
575 Granite Court
Pickering
L1W 3W8
Ontario
CANADA
CapsuleDIN 02125382Hydromorphone hydrochloride 24 mg

Reason

Affected lots may contain hydromorphone levels outside of the labelled claim.

Depth of distribution

Wholesalers, Retailers, Healthcare Establishments
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime